Risedronate (sodium salt) Reference: 20740-1 An aminobisphosphonate and antimalarial agent that inhibits bone resorption; inhibits growth of P. falciparum in vitro (IC50 = 20.3 µM) and P. berghei in vivo (25 mg/kg for one week); inhibits protein prenylation by preventing transfer of a farnesyl pyrophosphate group to parasite proteins
Risedronate (sodium salt) Reference: 20740-250 An aminobisphosphonate and antimalarial agent that inhibits bone resorption; inhibits growth of P. falciparum in vitro (IC50 = 20.3 µM) and P. berghei in vivo (25 mg/kg for one week); inhibits protein prenylation by preventing transfer of a farnesyl pyrophosphate group to parasite proteins
Risedronate (sodium salt) Reference: 20740-5 An aminobisphosphonate and antimalarial agent that inhibits bone resorption; inhibits growth of P. falciparum in vitro (IC50 = 20.3 µM) and P. berghei in vivo (25 mg/kg for one week); inhibits protein prenylation by preventing transfer of a farnesyl pyrophosphate group to parasite proteins
Risedronate (sodium salt) Reference: 20740-500 An aminobisphosphonate and antimalarial agent that inhibits bone resorption; inhibits growth of P. falciparum in vitro (IC50 = 20.3 µM) and P. berghei in vivo (25 mg/kg for one week); inhibits protein prenylation by preventing transfer of a farnesyl pyrophosphate group to parasite proteins
7-epi Paclitaxel Reference: 20741-1 An active metabolite of paclitaxel; exhibits properties comparable to paclitaxel on both cells and in vitro microtubule polymerization
7-epi Paclitaxel Reference: 20741-10 An active metabolite of paclitaxel; exhibits properties comparable to paclitaxel on both cells and in vitro microtubule polymerization